NAII

Natural Alternatives International

NAII.US nai-online.com
1.96
-0.06 (-2.97%)
USD · NASDAQ
52-week range
1.94
4.96
Trading at 1% of the 52-week range
Market Cap
12.30M
P/E Ratio
0.00
Forward P/E
13.61
Book Value
10.34
Div. Yield
N/A
% Institutions
36.34%
% Insiders
21.68%

1 Year

-45.4%

3 Year

-69.9%

10 Year

-81.2%
Description

Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. It operates through two segments: Private-Label Contract Manufacturing, and Patent and Trademark Licensing. The company offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. It also provides strategic partnering services, such as customized product formulation, clinical study design and support, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management, packaging and delivery system design, regulatory review, and international product registration assistance. In addition, the company sells beta-alanine ingredient under the CarnoSyn, TriBsynm, and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.

Company Information

Company Name
Natural Alternatives International
Sector
Consumer Defensive
Industry
Packaged Foods
Exchange
NASDAQ
ISIN: US6388423021
CIK: 0000787253
CUSIP: 638842302
Currency: USD
Full Time Employees: 293
Phone: 760 744 7700
Fiscal Year End: June
IPO Date: Mar 13, 1987
Description:

Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. It operates through two segments: Private-Label Contract Manufacturing, and Patent and Trademark Licensing. The company offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. It also provides strategic partnering services, such as customized product formulation, clinical study design and support, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management, packaging and delivery system design, regulatory review, and international product registration assistance. In addition, the company sells beta-alanine ingredient under the CarnoSyn, TriBsynm, and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.

Address:

1535 Faraday Avenue, Carlsbad, CA, United States, 92008

People

Directors & Officers

Name Title Year Born
Mr. Mark A. LeDoux J.D. Chairman of the Board & CEO 1954
Mr. Kenneth E. Wolf CPA President, COO, Secretary, Principal Financial & Principal Accounting Officer 1961
Mr. Shane Conti Vice President of Global Sales NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 06, 2026 Mark A Ledoux N/A Purchase 532.00 $2.80 $1.49K
Mar 05, 2026 Mark A Ledoux N/A Purchase 218.00 $2.75 $599.50
Mar 04, 2026 Mark A Ledoux N/A Purchase 500.00 $2.77 $1.39K
Mar 02, 2026 Mark A Ledoux N/A Purchase 500.00 $2.79 $1.40K
Feb 27, 2026 Mark A Ledoux N/A Purchase 250.00 $2.80 $700.00
Feb 27, 2026 Mark A Ledoux N/A Purchase 500.00 $2.85 $1.43K
Feb 25, 2026 Mark A Ledoux N/A Purchase 500.00 $2.81 $1.41K
Feb 24, 2026 Mark A Ledoux N/A Purchase 1.00K $2.71 $2.71K
Feb 23, 2026 Mark A Ledoux N/A Purchase 750.00 $2.70 $2.03K
Feb 20, 2026 Mark A Ledoux N/A Purchase 250.00 $2.65 $662.50
Feb 19, 2026 Mark A Ledoux N/A Purchase 1.50K $2.56 $3.84K
Feb 18, 2026 Mark A Ledoux N/A Purchase 500.00 $2.56 $1.28K
Feb 17, 2026 Mark A Ledoux N/A Purchase 2.50K $2.60 $6.50K

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
CALDWELL SUTTER CAPITAL INC 498.79K Mar 31, 2026 7.95% $0.53 8.01%
Dimensional Fund Advisors, Inc. 335.79K Jun 30, 2026 5.35% $0.00 -5.34%
Mink Brook Asset Management LLC 293.45K Jun 30, 2026 4.68% $0.31 -0.09%
Renaissance Technologies Corp 291.36K Mar 31, 2026 4.64% $0.00 -3.77%
Morgan Stanley - Brokerage Accounts 268.25K Mar 31, 2026 4.27% $0.00 13.07%
Vanguard Capital Management, LLC 210.88K Mar 31, 2026 3.36% $0.00 0.00%
Bridgeway Capital Management, LLC 75.32K Mar 31, 2026 1.20% $0.00 1.16%
Geode Capital Management, LLC 52.41K Mar 31, 2026 0.84% $0.00 23.25%
Citadel Advisors Llc 43.71K Mar 31, 2026 0.70% $0.00 198.82%
Vanguard Fiduciary Trust Co 27.10K Mar 31, 2026 0.43% $0.00 0.00%
Empowered Funds, LLC 24.91K Mar 31, 2026 0.40% $0.00 0.00%
Integrated Wealth Concepts LLC 12.00K Mar 31, 2026 0.19% $0.00 0.00%
State Street Corp 11.66K Mar 31, 2026 0.19% $0.00 0.00%
James Investment Research, Inc. 10.02K Jun 30, 2026 0.16% $0.00 0.00%
Goss Wealth Management LLC 10.02K Mar 31, 2026 0.16% $0.00 0.00%
Vanguard Global Advisers, LLC 2.82K Mar 31, 2026 0.04% $0.00 0.00%
Citigroup Inc 1.99K Mar 31, 2026 0.03% $0.00 199,000.00%
Tower Research Capital LLC 1.11K Mar 31, 2026 0.02% $0.00 2.68%
Royal Bank of Canada 31.00 Mar 31, 2026 0.00% $0.00 -67.71%
Gill Capital Partners 7.00 Mar 31, 2026 0.00% $0.00 0.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard MStar Total Stk Mkt Idx Invest 159.05K 2.53% ▲ 0.00% Jul 31, 2026
2 DFA US Small Cap Value I 141.53K 2.26% ▲ 0.00% Jul 31, 2026
3 DFA US Micro Cap I 67.14K 1.07% ▲ 0.00% Jul 31, 2026
4 Vanguard Institutional Extnd Mkt Idx Tr 51.84K 0.83% ▲ 0.00% Jul 31, 2026
5 DFA US Small Cap I 25.53K 0.41% ▲ 0.00% Jul 31, 2026
6 EA Bridgeway Omni Small-Cap Value ETF 24.91K 0.40% ▲ 0.00% Aug 31, 2026
7 Fidelity Extended Market Index 21.11K 0.34% ▲ 0.00% Jul 31, 2026
8 Bridgeway Omni Small-Cap Value N 18.10K 0.29% ▲ 0.00% Jun 30, 2026
9 Bridgeway Omni Small-Cap Value 18.10K 0.29% ▲ 0.00% Jun 30, 2026
10 Dimensional US Small Cap ETF 16.92K 0.27% ▲ 0.00% Aug 31, 2026

Financial Highlights

Market Cap: $12.30M
EBITDA: $-1.44M
PEG Ratio: $5.41
Book Value: $10.34
Earnings/Share: $-2.40
Profit Margin: -10.13%
Operating Margin: -11.31%
ROA (TTM): -2.47%
ROE (TTM): -20.57%
Revenue (TTM): $141.87M
Revenue/Share (TTM): $23.60
Earnings Growth (YOY): 74.10%
Revenue Growth (YOY): 23.30%

Valuation Metrics

Enterprise Value: $68.27M
Trailing P/E: 0.00
Forward P/E: 13.61

Shares Statistics

Shares Outstanding: 6.28M
Shares Float: 4.93M
% Insiders: 21.68%
% Institutions: 36.34%
Short % Float: 0.15%

Stock Price History

1 Year Price History

3 Years Price History

10 Years Price History

Financial Charts

Revenue, Net Income & Operating Cash Flow (Yearly)

Revenue, Net Income & Operating Cash Flow (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$129.86M
Cost of Goods Sold
adjust
$-120.57M
Gross Profit
subtotal
$9.29M
SG&A
adjust
$-16.15M
R&D
adjust
$-1.80M
Operating Income
subtotal
$-8.66M
Other / Non-Operating Items
adjust
$-4.92M
Net Income
subtotal
$-13.58M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about NAII.US!